Life sciences company announces move to London’s White City
A firm developing improved immunotherapies for a range of malignant diseases has moved into London’s White City life sciences cluster.
GammaDelta Therapeutics will become the latest life sciences company to take space at White City Place, the 1.9 million sq ft business, innovation and life sciences district in West London alongside Imperial College’s White City Campus.
GammaDelta will join fellow innovators Autolus and Synthace in White City Place and OpenCell, Rebelbio and Blenheim Chalcot will be their neighbours in the London Borough of Hammersmith & Fulham.
Moving from the London BioScience Innovation Centre near St Pancras, GammaDelta will be taking approximately 12,000 sq ft of office and lab space in the WestWorks building, which it will use as its base to develop immunotherapies for cancer and other serious immune-related diseases.
GammaDelta also has a research facility within the Incubator at the Translation and Innovation Hub at Imperial College London.
Founded in 2016 by transatlantic bioscience investment firm Abingworth, based on pioneering research conducted at King’s College London and The Francis Crick Institute into gamma delta T cells, GammaDelta is developing improved immunotherapies for a range of malignant diseases.
David Camp, chief executive of Stanhope, one of the developers and owners of White City Place, said: “GammaDelta is an exciting and innovative life sciences company and we are delighted that they are the latest addition to our thriving centre of technology and innovation in WestWorks.
“They join a list of names such as Novartis, Autolus and Synthace, which all contribute to the fast-paced and forward-thinking ethos of White City Place.”
Elichiro Onozawa, managing director of Mitsui Fudosan, who co-own and develop White City Place, added: “The arrival of GammaDelta to WestWorks highlights once again the transformation of the area into a hub of scientific and technological innovation.
“With the renovation of White City Place and the development of Imperial College’s new campus, White City has asserted itself as the destination of choice for any life sciences company looking to bring their exciting ideas and new approaches to London.”
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning London email for free.
Why local government is key to devolution success
Your reputation is worth more than that invoice
There is no perfect time when selling a business
What next when social media career help goes?
The psychological contract that nobody signs
Time for strategy built on the foundational economy
Why being ‘work-ready’ matters more than ever
The North's future doesn't end at Manchester
Exit or legacy? Why every owner needs a plan
Who speaks up for SMEs when giants get bigger?
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs